US2012309955A1PendingUtilityA1

Zwitterionic polysaccharides for promotion of immune system maturation and health

65
Assignee: KASPER DENNIS LPriority: Feb 6, 2006Filed: Jun 11, 2012Published: Dec 6, 2012
Est. expiryFeb 6, 2026(expired)· nominal 20-yr term from priority
A23L 33/10A23L 33/26A61P 1/00
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Certain zwitterionic polysaccharides, including those naturally expressed by commensal B. fragilis in the gut, interact with cells of the immune system and affect the T H 1/T H 2 balance so as to promote health. Nutritional formulas and nutritional supplements containing isolated preparations of such zwitterionic polysaccharides, and methods for preparing the nutritional formulas and supplements, are provided. Also provided is a method of promoting immune system maturation in an infant involving enteral administration of a nutritional formula or nutritional supplement of the invention.

Claims

exact text as granted — not AI-modified
1 . A nutritional formula or nutritional supplement composition, comprising an isolated zwitterionic polysaccharide consisting essentially of repeating units, wherein each repeating unit comprises
 two to ten monosaccharides, and   free amino moiety and a negatively charged moiety selected from the group consisting of carboxylate, phosphate, phosphonate, sulfate, and sulfonate.   
     
     
         2 . The composition of  claim 1 , wherein the zwitterionic polysaccharide is a naturally occurring bacterial capsular polysaccharide. 
     
     
         3 . The composition of  claim 1 , wherein the zwitterionic polysaccharide is a  B. fragilis  capsular polysaccharide A (PSA). 
     
     
         4 . The composition of  claim 3 , wherein the PSA is PSA1. 
     
     
         5 . The composition of  claim 3 , wherein the PSA is PSA2. 
     
     
         6 . The composition of  claim 1 , wherein the zwitterionic polysaccharide is a  B. fragilis  capsular polysaccharide B (PSB). 
     
     
         7 . The composition of  claim 1 , wherein the zwitterionic polysaccharide is selected from the group consisting of  Shigella sonnei  Phase I lipopolysaccharide 0-antigen,  Streptococcus pneumoniae  type 1 capsular polysaccharide, and  Streptococcus pneumoniae  group antigen C substance. 
     
     
         8 . The composition of  claim 1 , wherein the nutritional formula or nutritional supplement is a nutritional formula. 
     
     
         9 . The composition of  claim 1 , wherein the nutritional formula or nutritional supplement is a nutritional supplement. 
     
     
         10 - 32 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.